Clinical Trial Update: Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nerispirdine in multiple sclerosis has reported on its efficacy, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Nerispirdine (nerispirdine)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED